Emisphere Message Board - Msg: 17577570

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Emisphere

EMIS 9.950

-0.6%

Jan 9 11:18 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (176)	6/8/2002 11:15:38 PM
From: hmpa	Read Replies (1) of 272

Status of oral insulin: media.corporate-ir.net Oral Insulin Product Class: Protein Indication: Type I and II Diabetes Partnership Status: Discussions ongoing with major Pharma Development Status: Phase II studies ongoing CY02 Accomplishments: Euglycemic Clamp Study completed; 90-day toxicology studies completed; fed/fast study ongoing Upcoming CY02 Milestones: Development of tablet formulation; Presentation of Phase I data at American Diabetes Association 6/16/02 Previous slide Next slide Back to first slide View graphic version Slide 15 of 30

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next